Publications by authors named "Marc A Pfeffer"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

97,775

Total Likes

2,945

Extended Reach

2,574,791

Social Features

391
A
Angiotensin Receptor-Neprilysin Inhibition in Acute Myocardial Infarction.
Marc A Pfeffer, Brian Claggett, Eldrin F Lewis, Christopher B Granger, Lars Køber, Aldo P Maggioni, Douglas L Mann, John J V McMurray, Jean-Lucien Rouleau, Scott D Solomon

N Engl J Med· November 2021

Videos about Article: user user

2 5 177 5 12

View All Article and Social Media Activity
A
Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction.
Scott D Solomon, John J V McMurray, Inder S Anand, Junbo Ge, Carolyn S P Lam, Aldo P Maggioni, Felipe Martinez, Milton Packer, Marc A Pfeffer, Burkert Pieske

October 2019

Videos about Article: user user user 1

4 22 180 6 71

View All Article and Social Media Activity
L
Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome.
Marc A Pfeffer, Brian Claggett, Rafael Diaz, Kenneth Dickstein, Hertzel C Gerstein, Lars V Køber, Francesca C Lawson, Lin Ping, Xiaodan Wei, Eldrin F Lewis

N Engl J Med· December 2015

Videos about Article: user user

2 9 11 3 15

View All Article and Social Media Activity
A
A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease.
Marc A Pfeffer, Emmanuel A Burdmann, Chao-Yin Chen, Mark E Cooper, Dick de Zeeuw, Kai-Uwe Eckardt, Jan M Feyzi, Peter Ivanovich, Reshma Kewalramani, Andrew S Levey

November 2009

Videos about Article: user user

2 1 2 12 6 8

View All Article and Social Media Activity
D
Differences in Characteristics and Clinical Outcomes According to Age in Patients Following High-Risk Myocardial Infarction: Insights from PARADISE-MI.
Karola Simone Jering, Brian Lee Claggett, Offer Amir, Maja Cikes, Marc J Claeys, Marc Alan Pfeffer

Am J Cardiol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Tolerability of Sotagliflozin Among Kidney Transplant Recipients.
Martina M McGrath, Finnian R Mc Causland, Brian L Claggett, Andrew S Levey, Karela Herrera-Enriquez, Marc A Pfeffer

Transplantation· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adiposity-Related Anthropometrics and Clinical Outcomes in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: A Participant-Level Pooled Analysis of Randomized Clinical Trials.
John W Ostrominski, Mats C Højbjerg Lassen, Jawad H Butt, Brian L Claggett, Inder S Anand, Marc A Pfeffer

J Am Coll Cardiol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Natriuretic Peptides, Body Mass Index, and Clinical Outcomes in Heart Failure With Mildly Reduced or Preserved Ejection Fraction.
John W Ostrominski, Brendon L Neuen, Brian L Claggett, Inder S Anand, Akshay S Desai, Marc A Pfeffer

J Am Coll Cardiol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endothelin-1 and Cardio-Kidney Events among Patients with Chronic Kidney Disease, Diabetes, and Anemia.
Finnian R Mc Causland, Brian L Claggett, Petr Jarolim, Martina M McGrath, Emmanuel A Burdmann, Marc A Pfeffer

Am J Nephrol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Capturing Totality of Treatment Effects: A Model-Free Approach to Analyzing Multiple Event-Time Data From Heart Failure Studies.
Stephanie Armbruster, Zachary R McCaw, Karola Jering, Brian L Claggett, Muthiah Vaduganathan, Marc A Pfeffer

JACC Heart Fail· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Future myocardial infarction after an acute coronary syndrome and pharmacogenetic response to dalcetrapib.
Jean-Claude Tardif, Marc A Pfeffer, Simon Kouz, Wolfgang Koenig, Aldo P Maggioni

Eur J Prev Cardiol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Digitoxin - A Reminder for Digoxin.
Marc A Pfeffer

N Engl J Med· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to Cleland and Anzar.
Janet Wittes, David L DeMets, KyungMann Kim, Dennis G Maki, Marc A Pfeffer

Clin Trials· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aspirin in primary prevention: Undue reliance on an uninformative trial led to misinformed clinical guidelines.
Janet Wittes, David L DeMets, KyungMann Kim, Dennis G Maki, Marc A Pfeffer

Clin Trials· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Obesity and Risk of Kidney Outcomes in Heart Failure With Preserved Ejection Fraction: A Participant-Level Pooled Analysis of 4 Contemporary Trials.
Mats C H Lassen, John W Ostrominski, Brian L Claggett, Brendon L Neuen, Iris E Beldhuis, Marc A Pfeffer

JACC Heart Fail· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term outcomes of recurrent myocardial infarction: a nationwide Danish study.
Daniel Mølager Christensen, Deewa Zahir, Caroline Hartwell Garred, Nina Nouhravesh, Mariam Elmegaard, Marc A Pfeffer

Eur Heart J Acute Cardiovasc Care· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Application of a transthyretin amyloid cardiomyopathy score to heart failure with mildly reduced or preserved ejection fraction.
Riccardo M Inciardi, Muthiah Vaduganathan, Brian Claggett, Omar F AbouEzzeddine, Barry A Borlaug, Marc A Pfeffer

Eur J Heart Fail· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NT-proBNP in the Early Convalescent Phase after High-Risk Myocardial Infarction Is Associated with Adverse Cardiovascular Outcomes: the PARADISE-MI Trial.
Karola S Jering, Brian L Claggett, Eugene Braunwald, Christopher B Granger, Lars Køber, Marc A Pfeffer

J Card Fail· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association between body mass index and clinical outcomes in patients with acute myocardial infarction and reduced systolic function: Analysis of PARADISE-MI trial data.
Offer Amir, Gabby Elbaz-Greener, Shemy Carasso, Brian Claggett, Olga Barbarash, Marc A Pfeffer

Eur J Heart Fail· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mortality after high-risk myocardial infarction over the last 20 years: Insights from the VALIANT and PARADISE-MI trials.
Alberto Foà, Maria A Pabon, Eugene Braunwald, Karola Jering, Muthiah Vaduganathan, Marc A Pfeffer

Eur J Heart Fail· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systolic Blood Pressure and Pulse Pressure in Heart Failure: Pooled Participant-Level Analysis of 4 Trials.
Henri Lu, Toru Kondo, Brian L Claggett, Muthiah Vaduganathan, Brendon L Neuen, Marc A Pfeffer

J Am Coll Cardiol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Race in Heart Failure: A Pooled Participant-Level Analysis of the Global PARADIGM-HF and PARAGON-HF Trials.
Henri Lu, Brian L Claggett, Milton Packer, Maria A Pabon, Marc A Pfeffer

JACC Heart Fail· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Visit-to-visit changes in heart rate in heart failure: A pooled participant-level analysis of the PARADIGM-HF and PARAGON-HF trials.
Henri Lu, Brian L Claggett, Milton Packer, Marc A Pfeffer, Karl Swedberg

Eur J Heart Fail· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Happy birthday, Dr Braunwald!
Peter Libby, Marc A Pfeffer

Eur Heart J· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Angiotensin Receptor Neprilysin Inhibition and Cardiovascular Outcomes Across the Kidney Function Spectrum: The PARAGON-HF Trial.
Finnian R Mc Causland, Muthiah Vaduganathan, Brian Claggett, Mauro Gori, Pardeep S Jhund, Marc A Pfeffer

JACC Heart Fail· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of sacubitril/valsartan in heart failure with preserved ejection fraction across the age spectrum in PARAGON-HF.
Xiaowen Wang, Orly Vardeny, Brian Claggett, Muthiah Vaduganathan, Sheila M Hegde, Marc A Pfeffer

Eur J Heart Fail· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiparametric Assessment of Right Ventricular Dysfunction in Heart Failure: An Analysis From PARAGON-HF.
Henri Lu, Riccardo M Inciardi, Martin Abanda, Amil M Shah, Maja Cikes, Marc A Pfeffer

J Am Heart Assoc· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Undiagnosed Diabetes in Heart Failure With Preserved Ejection Fraction.
John W Ostrominski, Mats C Højbjerg Lassen, Brian L Claggett, Akshay S Desai, Marc A Pfeffer

JACC Heart Fail· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Centrally adjudicated vs. investigator-reported outcomes in randomized heart failure trials.
Simon Wandel, Akshay S Desai, Chien-Wei Chen, John J V McMurray, Milton Packer, Marc A Pfeffer

Eur Heart J· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis